Testing effectiveness (Phase 2)Study completedNCT04148287
What this trial is testing
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
Who this might be right for
CandidemiaInvasive CandidiasesCandida Infection
Basilea Pharmaceutica 9